Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for nonalcoholic steatohepatitis
IRCT20161210031316N2Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in metabolic dysfunction-associated steatohepatitis (MASH) comparing Losartan with Placebo (2 arms). Primary endpoints: AST, ALT and 2 more. Started Nov 2016; status: completed.
02
Drugs
losartan
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on IRCT20161210031316N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161210031316N2.